Clinical Trial Update: Partial Response to PPI Treatment: The Cost to Society and the Burden to the Patient - a Study in France

View source ↗

Summary

A completed clinical trial in France evaluating the societal costs and patient burden associated with partial response to proton pump inhibitor therapy for Gast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Status: COMPLETED